Xtant Medical Holdings (XTNT) Shares Outstanding (Diluted Average) (2010 - 2025)

Xtant Medical Holdings (XTNT) has 16 years of Shares Outstanding (Diluted Average) data on file, last reported at $150.0 million in Q4 2025.

• Quarterly Shares Outstanding (Diluted Average) rose 12.25% year-over-year to $150.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $150.0 million (up 12.25% YoY) and the FY2025 annual result came in at $150.0 million, up 12.25% from the prior year.
• Shares Outstanding (Diluted Average) steadied at $150.0 million in Q4 2025 per XTNT's latest filing, from $149.9 million in the prior quarter.
• Across five years, Shares Outstanding (Diluted Average) topped out at $150.0 million in Q4 2025 and bottomed at $81.2 million in Q1 2021.
• The 5-year median for Shares Outstanding (Diluted Average) is $116.4 million (2023), against an average of $114.3 million.
• The widest annual swing landed in 2021, when Shares Outstanding (Diluted Average) surged 555.7%; it then rose 0.63% in 2022.
• Tracing XTNT's Shares Outstanding (Diluted Average) over 5 years: stood at $85.5 million in 2021, then increased by 10.1% to $94.1 million in 2022, then jumped by 34.76% to $126.8 million in 2023, then advanced by 5.42% to $133.7 million in 2024, then grew by 12.25% to $150.0 million in 2025.
• Per Business Quant, the three latest XTNT Shares Outstanding (Diluted Average) figures stand at $150.0 million (Q4 2025), $149.9 million (Q3 2025), and $148.6 million (Q2 2025).

Peer Comparison